Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Yang-Feng Lv, Zhi-Qiang Deng, Qiu-Chen Bi, Jian-Jun Tang, Hong Chen, Chuan-Sheng Xie, Qing-Rong Liang, Yu-Hua Xu, Rong-Guang Luo & Qun Tang. (2022) Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin. Drug Delivery 29:1, pages 1743-1753.
Read now
Read now
Clara Vigneron, Adrien Mirouse, Hamid Merdji, Christophe Rousseau, Clément Cousin, Fanny Alby-Laurent, Jean-Paul Mira, Jean-Daniel Chiche, Jean-François Llitjos & Frédéric Pène. (2019) Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced Natural Killer cell activity. OncoImmunology 8:11.
Read now
Read now
Xupeng Bai, Yibei Chen, Xiangyu Hou, Min Huang & Jing Jin. (2016) Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metabolism Reviews 48:4, pages 541-567.
Read now
Read now
Seok Hwee Koo, Ying Li Lo, Jie Yin Yee & Edmund Jon Deoon Lee. (2015) Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity. Expert Opinion on Drug Metabolism & Toxicology 11:12, pages 1821-1837.
Read now
Read now
Michael Wiese. (2015) BCRP/ABCG2 inhibitors: a patent review (2009 – present). Expert Opinion on Therapeutic Patents 25:11, pages 1229-1237.
Read now
Read now
Curtis D. Klaassen, Hong Lu & Julia Yue Cui. (2011) Epigenetic regulation of drug processing genes. Toxicology Mechanisms and Methods 21:4, pages 312-324.
Read now
Read now
Ying Huang, Sravan Penchala, Anh-Nhan Pham & Jeffrey Wang. (2008) Genetic variations and gene expression of transporters in drug disposition and response. Expert Opinion on Drug Metabolism & Toxicology 4:3, pages 237-254.
Read now
Read now
Joel A Lefferts, Claudine L Bartels & Gregory J Tsongalis. (2007) Pharmacogenetics: where are we with respect to personalized medicine?. Expert Opinion on Medical Diagnostics 1:1, pages 117-128.
Read now
Read now
Marion M Schuierer & Thomas Langmann. (2005) Molecular diagnosis of ATP-binding cassette transporter-related diseases. Expert Review of Molecular Diagnostics 5:5, pages 755-767.
Read now
Read now
Nicole HP Cnubben, Heleen M Wortelboer, Jelmer J van Zanden, Ivonne MCM Rietjens & Peter J van Bladeren. (2005) Metabolism of ATP-binding cassette drug transporter inhibitors: complicating factor for multidrug resistance. Expert Opinion on Drug Metabolism & Toxicology 1:2, pages 219-232.
Read now
Read now
Articles from other publishers (56)
Barun Majumder, Sadna Budhu & Vitaly V. Ganusov. (2023) Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen–Fibrin Gels by Cytolytic and Non-Lytic Mechanisms. Viruses 15:7, pages 1454.
Crossref
Crossref
Sung Hye Kong, Joon-Hyop Lee, Jeong Mo Bae, Namki Hong, Hyeyoon Kim, So Young Park, Yong Jun Choi, Sihoon Lee, Yumie Rhee, Sang Wan Kim, Dohyun Han, Jung Hee Kim & Chan Soo Shin. (2023) In-depth proteomic signature of parathyroid carcinoma. European Journal of Endocrinology 188:4, pages 385-394.
Crossref
Crossref
Paweł Stachura, Olivia Stencel, Zhe Lu, Arndt Borkhardt & Aleksandra A. Pandyra. (2023) Arenaviruses: Old viruses present new solutions for cancer therapy. Frontiers in Immunology 14.
Crossref
Crossref
Susan N. Payne, Philip B. Emmerich, Nicole M. Davis, Dustin A. Deming & Laura J. Knoll. (2021) Novel Murine Pancreatic Tumor Model Demonstrates Immunotherapeutic Control of Tumor Progression by a Toxoplasma gondii Protein. Infection and Immunity 89:12.
Crossref
Crossref
Allison A Fitzgerald, Shangzi Wang, Veena Agarwal, Emily F Marcisak, Annie Zuo, Sandra A Jablonski, Melanie Loth, Elana J Fertig, John MacDougall, Eugene Zhukovsky, Shubhendu Trivedi, Dimple Bhatia, Vince O'Neill & Louis M Weiner. (2021) DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer 9:11, pages e002837.
Crossref
Crossref
Marc Carceles-Cordon, W. Kevin Kelly, Leonard Gomella, Karen E. Knudsen, Veronica Rodriguez-Bravo & Josep Domingo-Domenech. (2020) Cellular rewiring in lethal prostate cancer: the architect of drug resistance. Nature Reviews Urology 17:5, pages 292-307.
Crossref
Crossref
Yin Wang, Zhenhao Liu, Baofeng Lian, Lei Liu & Lu Xie. (2019) Integrative Analysis of Dysfunctional Modules Driven by Genomic Alterations at System Level Across 11 Cancer Types. Combinatorial Chemistry & High Throughput Screening 21:10, pages 771-783.
Crossref
Crossref
Masato Kobayashi, Takafumi Tsujiuchi, Yuya Okui, Asuka Mizutani, Kodai Nishi, Takeo Nakanishi, Ryuichi Nishii, Kazuki Fukuchi, Ikumi Tamai & Keiichi Kawai. (2018) Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer. Pharmaceutical Research 36:1.
Crossref
Crossref
Boyang Sun, Robert M. Straubinger & Jonathan F. Lovell. (2018) Current taxane formulations and emerging cabazitaxel delivery systems. Nano Research 11:10, pages 5193-5218.
Crossref
Crossref
Nate J. Dwarshuis, Kirsten Parratt, Adriana Santiago-Miranda & Krishnendu Roy. (2017) Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies. Advanced Drug Delivery Reviews 114, pages 222-239.
Crossref
Crossref
Carolina Witchmichen Penteado Schmidt & Fabiana Gatti de MenezesCarolina Witchmichen Penteado Schmidt & Fabiana Gatti de Menezes. 2017. Drug Therapy and Interactions in Pediatric Oncology. Drug Therapy and Interactions in Pediatric Oncology
125
175
.
Aziz Hichami, Akadiri Yessoufou, François Ghiringhelli, Françoise Salvadori, Kabirou Moutairou, Narcisse Zwetyenga & Naim Akhtar Khan. (2016) Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice. Biochimie 131, pages 1-10.
Crossref
Crossref
Kyu-Won Kim, Jae Kyung Roh, Hee-Jun Wee & Chan KimKyu-Won Kim, Jae Kyung Roh, Hee-Jun Wee & Chan Kim. 2016. Cancer Drug Discovery. Cancer Drug Discovery
113
134
.
Dass S. Vinay, Elizabeth P. Ryan, Graham Pawelec, Wamidh H. Talib, John Stagg, Eyad Elkord, Terry Lichtor, William K. Decker, Richard L. Whelan, H.M.C. Shantha Kumara, Emanuela Signori, Kanya Honoki, Alexandros G. Georgakilas, Amr Amin, William G. Helferich, Chandra S. Boosani, Gunjan Guha, Maria Rosa Ciriolo, Sophie Chen, Sulma I. Mohammed, Asfar S. Azmi, W. Nicol Keith, Alan Bilsland, Dipita Bhakta, Dorota Halicka, Hiromasa Fujii, Katia Aquilano, S. Salman Ashraf, Somaira Nowsheen, Xujuan Yang, Beom K. Choi & Byoung S. Kwon. (2015) Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Seminars in Cancer Biology 35, pages S185-S198.
Crossref
Crossref
S. Sarkar, N. Cohen, P. Sabhachandani & T. Konry. (2015) Phenotypic drug profiling in droplet microfluidics for better targeting of drug-resistant tumors. Lab on a Chip 15:23, pages 4441-4450.
Crossref
Crossref
Sabina Dizdarevic & Adrien Michael Peters. 2015. Resistance to Targeted ABC Transporters in Cancer. Resistance to Targeted ABC Transporters in Cancer
133
151
.
Sarah L Doyle, Peter Adamson, Francisco J López, Peter Humphries & Matthew Campbell. (2014) Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration. Nature Medicine 20:12, pages 1376-1377.
Crossref
Crossref
Kenneth H. Yu, Mark Ricigliano, Manuel Hidalgo, Ghassan K. Abou-Alfa, Maeve A. Lowery, Leonard B. Saltz, Joseph F. Crotty, Kristen Gary, Brandon Cooper, Rena Lapidus, Mariola Sadowska & Eileen M. O'Reilly. (2014) Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer. Clinical Cancer Research 20:20, pages 5281-5289.
Crossref
Crossref
Keri L. Schadler, Erika J. Crosby, Alice Yao Zhou, Dong Ha Bhang, Lior Braunstein, Kwan Hyuck Baek, Danielle Crawford, Alison Crawford, Jill Angelosanto, E. John Wherry & Sandra Ryeom. (2014) Immunosurveillance by Antiangiogenesis: Tumor Growth Arrest by T Cell–Derived Thrombospondin-1. Cancer Research 74:8, pages 2171-2181.
Crossref
Crossref
Dominick L. Auci, Denise L. Cecil, Daniel Herendeen, Elizabeth K. Broussard, John B. Liao, Gregory E. Holt & Mary L. Disis. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
335
343
.
Yanbin Zhao, Hailing Lu, An Yan, Yanmei Yang, Qingwei Meng, Lichun Sun, Hui Pang, Chunhong Li, Xiaoqun Dong & Li Cai. (2013) ABCC3 as a marker for multidrug resistance in non-small cell lung cancer. Scientific Reports 3:1.
Crossref
Crossref
Erin E. Ezzell, Kuang S. Chang & Benjamin J. George. (2013) New Agents in the Arsenal to Fight Castrate-Resistant Prostate Cancer. Current Oncology Reports 15:3, pages 239-248.
Crossref
Crossref
Cristian B. Villanueva, Fernando F. Bazan & Xavier B. Pivot. (2013) New Microtubule Inhibitors in Breast Cancer. Current Breast Cancer Reports 5:1, pages 1-10.
Crossref
Crossref
Fabien CalcagnoThierry NguyenErion DobiCristian VillanuevaElsa CurtitStefano KimPhilippe MontcuquetFrançois KleinclaussXavier PivotAntoine Thiery-Vuillemin. (2012) Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer. Clinical Medicine Insights: Oncology 7, pages CMO.S7256.
Crossref
Crossref
Alain C. Mita, Robert Figlin & Monica M. Mita. (2012) Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?. Clinical Cancer Research 18:24, pages 6574-6579.
Crossref
Crossref
Jian Yuan, Iris L.K. Wong, Tao Jiang, Si Wen Wang, Tao Liu, Bin Jin Wen, Larry M.C. Chow & Biao Wan Sheng. (2012) Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells. European Journal of Medicinal Chemistry 54, pages 413-422.
Crossref
Crossref
Jean-François Lévesque, Kelly Bleasby, Amandine Chefson, Austin Chen, Daniel Dubé, Yves Ducharme, Pierre-André Fournier, Sébastien Gagné, Michel Gallant, Erich Grimm, Michael Hafey, Yongxin Han, Robert Houle, Patrick Lacombe, Sébastien Laliberté, Dwight MacDonald, Bruce Mackay, Robert Papp & Richard Tschirret-Guth. (2011) Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters 21:18, pages 5547-5551.
Crossref
Crossref
Aline Bolpetti, João S Silva, Luisa L Villa & Ana Paula Lepique. (2010) Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. BMC Immunology 11:1.
Crossref
Crossref
Lilit Garibyan & David E. Fisher. (2010) How Sunlight Causes Melanoma. Current Oncology Reports 12:5, pages 319-326.
Crossref
Crossref
Joseph L. Sottnik, Lance W. U?Ren, Douglas H. Thamm, Stephen J. Withrow & Steven W. Dow. (2009) Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunology, Immunotherapy 59:3, pages 367-378.
Crossref
Crossref
T Liu & A K Chopra. (2009) An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth. Cancer Gene Therapy 17:2, pages 97-108.
Crossref
Crossref
Beena John, Tajie H. Harris, Elia D. Tait, Emma H. Wilson, Beth Gregg, Lai Guan Ng, Paulus Mrass, David S. Roos, Florence Dzierszinski, Wolfgang Weninger & Christopher A. Hunter. (2009) Dynamic Imaging of CD8+ T Cells and Dendritic Cells during Infection with Toxoplasma gondii. PLoS Pathogens 5:7, pages e1000505.
Crossref
Crossref
Sang Kyun Park, Min Kyoung Cho, Hye-Kyung Park, Keun Hee Lee, Sun Joo Lee, Seon Hee Choi, Mee Sun Ock, Hae Jin Jeong, Moo Hyung Lee & Hak Sun Yu. (2009)
Macrophage Migration Inhibitory Factor Homologs of
Anisakis simplex
Suppress Th2 Response in Allergic Airway Inflammation Model via CD4+CD25+Foxp3+ T Cell Recruitment
. The Journal of Immunology 182:11, pages 6907-6914.
Crossref
Crossref
Basel K. al-Ramadi, Maria J. Fernandez-Cabezudo, Hussain El-Hasasna, Suhail Al-Salam, Ghada Bashir & Salem Chouaib. (2009) Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis. Clinical Immunology 130:1, pages 89-97.
Crossref
Crossref
Stefan Leyers, Hans-Georg H?cker, Jeanette Wiendlocha, Michael G?tschow & Michael Wiese. (2008) A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins. Bioorganic & Medicinal Chemistry Letters 18:17, pages 4761-4763.
Crossref
Crossref
Erika Cecchin, Massimo Libra, Calogero Cannavò, Bibiana Bruni, Alberto Fulvi, Giuseppe Toffoli & Franca Stivala. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
389
403
.
Ho-Sook Kim, Yu Eun Sunwoo, Ji Young Ryu, Ho-Jin Kang, Hye-Eun Jung, Im-Sook Song, Eun-Young Kim, Joo-Cheol Shim, Ji-Hong Shon & Jae-Gook Shin. (2007) The effect of ABCG2?V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine. British Journal of Clinical Pharmacology 64:5, pages 645-654.
Crossref
Crossref
Pornngarm Limtrakul. 2007. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
269
300
.
Mark De Ridder, Valeri N. Verovski, Carlo Chiavaroli, Dirk L. Van den Berge, Christinne Monsaert, Kalun Law & Guy A. Storme. (2006) The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase. International Journal of Radiation Oncology*Biology*Physics 66:5, pages 1473-1480.
Crossref
Crossref
Delia Nelson & Ruth Ganss. (2006) Tumor growth or regression: powered by inflammation. Journal of Leukocyte Biology 80:4, pages 685-690.
Crossref
Crossref
Alexandre Loktionov. 2006. Nutrient-Drug Interactions. Nutrient-Drug Interactions
261
317
.
Seok Hwee Koo & Edmund Jon Deoon Lee. (2006) PHARMACOGENETICS APPROACH TO THERAPEUTICS. Clinical and Experimental Pharmacology and Physiology 33:5-6, pages 525-532.
Crossref
Crossref
William C. Zamboni, Sanjay Goel, Tahir Iqbal, Robert A. Parise, Sandra Strychor, Trisha V. W. Repinski, Merrill J. Egorin & Sridhar Mani. (2005) Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors. Cancer Chemotherapy and Pharmacology 57:5, pages 631-639.
Crossref
Crossref
Andrew R. Erdman, Lara M. Mangravite, Thomas J. Urban, Leah L. Lagpacan, Richard A. Castro, Melanie de la Cruz, Wendy Chan, Conrad C. Huang, Susan J. Johns, Michiko Kawamoto, Douglas Stryke, Travis R. Taylor, Elaine J. Carlson, Thomas E. Ferrin, Claire M. Brett, Esteban G. Burchard & Kathleen M. Giacomini. (2006)
The human organic anion transporter 3 (OAT3;
SLC22A8
): genetic variation and functional genomics
. American Journal of Physiology-Renal Physiology 290:4, pages F905-F912.
Crossref
Crossref
Yusuke Matsunaga, Akinobu Hamada, Isamu Okamoto, Ji-ichiro Sasaki, Eiji Moriyama, Hiroto Kishi, Mitsuhiro Matsumoto, Asumi Hira, Hiroshi Watanabe & Hideyuki Saito. (2006) Pharmacokinetics of Amrubicin and Its Active Metabolite Amrubicinol in Lung Cancer Patients. Therapeutic Drug Monitoring 28:1, pages 76-82.
Crossref
Crossref
Wendy J. Huss, Danny R. Gray, Norman M. Greenberg, James L. Mohler & Gary J. Smith. (2005) Breast Cancer Resistance Protein–Mediated Efflux of Androgen in Putative Benign and Malignant Prostate Stem Cells. Cancer Research 65:15, pages 6640-6650.
Crossref
Crossref
William L. PerryIIIIII, Robert L. Shepard, Janardhan Sampath, Benjamin Yaden, William W. Chin, Philip W. Iversen, Shengfang Jin, Andrea Lesoon, Kathryn A. O'Brien, Victoria L. Peek, Mark Rolfe, Andrew Shyjan, Michelle Tighe, Mark Williamson, Venkatesh Krishnan, Robert E. Moore & Anne H. Dantzig. (2005)
Human Splicing Factor SPF45 (
RBM17
) Confers Broad Multidrug Resistance to Anticancer Drugs When Overexpressed— a Phenotype Partially Reversed By Selective Estrogen Receptor Modulators
. Cancer Research 65:15, pages 6593-6600.
Crossref
Crossref
Martin McCarter, Jason Clarke, Donald Richter & Cara Wilson. (2005) Melanoma skews dendritic cells to facilitate a T helper 2 profile. Surgery 138:2, pages 321-328.
Crossref
Crossref
Douglas H. Thamm, Ilene D. Kurzman, Ivan King, Zujin Li, Mario Sznol, Richard R. Dubielzig, David M. Vail & E. Gregory MacEwen. (2005)
Systemic Administration of an Attenuated, Tumor-Targeting
Salmonella typhimurium
to Dogs with Spontaneous Neoplasia: Phase I Evaluation
. Clinical Cancer Research 11:13, pages 4827-4834.
Crossref
Crossref
C.M. Chung, C. Man, Y. Jin, C. Jin, X.Y. Guan, Q. Wang, T.S.K. Wan, A.L.M. Cheung & S.W. Tsao. (2005) Amplification and overexpression of Aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Molecular Carcinogenesis 43:3, pages 165-174.
Crossref
Crossref
Giampietro Gasparini, Raffaele Longo, Francesco Torino, Carlo Barone & Giuseppe Toffoli. (2005) Tailored Therapy of Colorectal Cancer. The Cancer Journal 11:3, pages 175-188.
Crossref
Crossref
Tomoe Fujita, Chaline Brown, Elaine J. Carlson, Travis Taylor, Melanie de la Cruz, Susan J. Johns, Doug Stryke, Michiko Kawamoto, Kazumi Fujita, Richard Castro, Chung-Wen Chen, Emil T. Lin, Claire M. Brett, Esteban Gonzalez Burchard, Thomas E. Ferrin, Conrad C. Huang, Maya K. Leabman & Kathleen M. Giacomini. (2005) Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenetics and Genomics 15:4, pages 201-209.
Crossref
Crossref
Erin R Lepper, Kees Nooter, Jaap Verweij, Milin R Acharya, William D Figg & Alex Sparreboom. (2005) Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics 6:2, pages 115-138.
Crossref
Crossref
Custer C. Deocaris, Kazunari Taira, Sunil C. Kaul & Renu Wadhwa. (2005) Mimotope-hormesis and mortalin/grp75/mthsp70: a new hypothesis on how infectious disease-associated epitope mimicry may explain low cancer burden in developing nations. FEBS Letters 579:3, pages 586-590.
Crossref
Crossref
Manon T. Huizing. 2005. Drugs Affecting Growth of Tumours. Drugs Affecting Growth of Tumours
101
131
.
Nicola F. Smith, William D. Figg & Alex Sparreboom. (2004) Recent advances in pharmacogenetic approaches to anticancer drug development. Drug Development Research 62:3, pages 233-253.
Crossref
Crossref